516 related articles for article (PubMed ID: 11314793)
21. RhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation.
Ristiniemi J; Flinkkilä T; Hyvönen P; Lakovaara M; Pakarinen H; Jalovaara P
J Bone Joint Surg Br; 2007 Feb; 89(2):265-72. PubMed ID: 17322450
[TBL] [Abstract][Full Text] [Related]
22. Treatment of allograft nonunions with recombinant human bone morphogenetic proteins (rhBMP).
Delloye C; Suratwala SJ; Cornu O; Lee FY
Acta Orthop Belg; 2004 Dec; 70(6):591-7. PubMed ID: 15669462
[TBL] [Abstract][Full Text] [Related]
23. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Haid RW; Branch CL; Alexander JT; Burkus JK
Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
[TBL] [Abstract][Full Text] [Related]
24. Effect of recombinant human osteogenic protein-1 on the healing of a freshly closed diaphyseal fracture.
den Boer FC; Bramer JA; Blokhuis TJ; Van Soest EJ; Jenner JM; Patka P; Bakker FC; Burger EH; Haarman HJ
Bone; 2002 Jul; 31(1):158-64. PubMed ID: 12110429
[TBL] [Abstract][Full Text] [Related]
25. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
Vaccaro AR; Whang PG; Patel T; Phillips FM; Anderson DG; Albert TJ; Hilibrand AS; Brower RS; Kurd MF; Appannagari A; Patel M; Fischgrund JS
Spine J; 2008; 8(3):457-65. PubMed ID: 17588821
[TBL] [Abstract][Full Text] [Related]
26. Canine investigation of rhBMP-2, autogenous bone graft, and rhBMP-2 with autogenous bone graft for the healing of a large segmental tibial defect.
Boyce AS; Reveal G; Scheid DK; Kaehr DM; Maar D; Watts M; Stone MB
J Orthop Trauma; 2009; 23(10):685-92. PubMed ID: 19858976
[TBL] [Abstract][Full Text] [Related]
27. Pulsed electromagnetic field stimulation for acute tibial shaft fractures: a multicenter, double-blind, randomized trial.
Adie S; Harris IA; Naylor JM; Rae H; Dao A; Yong S; Ying V
J Bone Joint Surg Am; 2011 Sep; 93(17):1569-76. PubMed ID: 21915570
[TBL] [Abstract][Full Text] [Related]
28. Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein-1 or autologous bone marrow.
den Boer FC; Wippermann BW; Blokhuis TJ; Patka P; Bakker FC; Haarman HJ
J Orthop Res; 2003 May; 21(3):521-8. PubMed ID: 12706026
[TBL] [Abstract][Full Text] [Related]
29. Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion.
White AP; Vaccaro AR; Hall JA; Whang PG; Friel BC; McKee MD
Int Orthop; 2007 Dec; 31(6):735-41. PubMed ID: 17962946
[TBL] [Abstract][Full Text] [Related]
30. Treatment of tibial shaft non-unions: bone morphogenetic proteins versus autologous bone graft.
Zimmermann G; Wagner C; Schmeckenbecher K; Wentzensen A; Moghaddam A
Injury; 2009 Dec; 40 Suppl 3():S50-3. PubMed ID: 20082792
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of recombinant human bone morphogenetic protein-2/calcium phosphate matrix for closed tibial diaphyseal fracture: a double-blind, randomized, controlled phase-II/III trial.
Lyon T; Scheele W; Bhandari M; Koval KJ; Sanchez EG; Christensen J; Valentin A; Huard F
J Bone Joint Surg Am; 2013 Dec; 95(23):2088-96. PubMed ID: 24306695
[TBL] [Abstract][Full Text] [Related]
32. Bone morphogenetic protein-2 compared to autologous iliac crest bone graft in the treatment of long bone nonunion.
Tressler MA; Richards JE; Sofianos D; Comrie FK; Kregor PJ; Obremskey WT
Orthopedics; 2011 Dec; 34(12):e877-84. PubMed ID: 22146205
[TBL] [Abstract][Full Text] [Related]
33. Outcomes and complication rates of different bone grafting modalities in long bone fracture nonunions: a retrospective cohort study in 182 patients.
Flierl MA; Smith WR; Mauffrey C; Irgit K; Williams AE; Ross E; Peacher G; Hak DJ; Stahel PF
J Orthop Surg Res; 2013 Sep; 8():33. PubMed ID: 24016227
[TBL] [Abstract][Full Text] [Related]
34. Osseointegration of autograft versus osteogenic protein-1 in posterolateral spinal arthrodesis: emphasis on the comparative mechanisms of bone induction.
Cunningham BW; Shimamoto N; Sefter JC; Dmitriev AE; Orbegoso CM; McCarthy EF; Fedder IL; McAfee PC
Spine J; 2002; 2(1):11-24. PubMed ID: 14588284
[TBL] [Abstract][Full Text] [Related]
35. External fixation of tibial pilon fractures and fracture healing.
Ristiniemi J
Acta Orthop Suppl; 2007 Jun; 78(326):3, 5-34. PubMed ID: 17465283
[TBL] [Abstract][Full Text] [Related]
36. [New-bone formation by osteogenic protein-1 and autogenic bone marrow in a critical tibial defect model in sheep].
Regauer M; Jürgens I; Kotsianos D; Stützle H; Mutschler W; Schieker M
Zentralbl Chir; 2005 Aug; 130(4):338-45. PubMed ID: 16103959
[TBL] [Abstract][Full Text] [Related]
37. Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone.
Johnson EE; Urist MR; Finerman GA
Clin Orthop Relat Res; 1992 Apr; (277):229-37. PubMed ID: 1555346
[TBL] [Abstract][Full Text] [Related]
38. Composite implant of native bovine bone morphogenetic protein (BMP), collagen carrier and biocoral in the treatment of resistant ulnar nonunions: report of five preliminary cases.
Kujala S; Raatikainen T; Ryhänen J; Kaarela O; Jalovaara P
Arch Orthop Trauma Surg; 2004 Jan; 124(1):26-30. PubMed ID: 14618346
[TBL] [Abstract][Full Text] [Related]
39. The synergistic effect of autograft and BMP-7 in the treatment of atrophic nonunions.
Giannoudis PV; Kanakaris NK; Dimitriou R; Gill I; Kolimarala V; Montgomery RJ
Clin Orthop Relat Res; 2009 Dec; 467(12):3239-48. PubMed ID: 19396502
[TBL] [Abstract][Full Text] [Related]
40. Treatment of critically sized femoral defects with recombinant BMP-2 delivered by a modified mPEG-PLGA biodegradable thermosensitive hydrogel.
Peng KT; Hsieh MY; Lin CT; Chen CF; Lee MS; Huang YY; Chang PJ
BMC Musculoskelet Disord; 2016 Jul; 17():286. PubMed ID: 27421654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
